The NIH grants termination lawsuit is one of the biggest legal battles in modern science. Since late 2024 and accelerating through 2025 and into 2026, the federal government has terminated or frozen billions of dollars in research grants, triggering lawsuits from dozens of universities and research institutions.
These cuts affect more than paperwork. Thousands of scientists, postdocs, graduate students, and lab technicians have lost funding. Entire research programs have shut down.
If you work in biomedical research or your institution received NIH funding, this fight directly involves you. This guide covers every major lawsuit, court ruling, legal theory, and practical step you need to know in 2026.
One number puts the scale in focus: the government has moved to cancel or claw back more than $30 billion in previously approved NIH grants.
NIH Grants Termination Lawsuit
The NIH grants termination lawsuit refers to a growing collection of federal court cases challenging the government's decision to cancel thousands of active research grants. These lawsuits argue that the terminations violate federal law, including the Administrative Procedure Act, the Impoundment Control Act, and constitutional due process protections.
The first wave of lawsuits began in early 2025. Universities like Harvard, Columbia, and the University of Pennsylvania filed suit after receiving sudden termination notices for grants that had already been approved, funded, and were mid-project.
By 2026, the number of active federal lawsuits related to NIH grant terminations has grown to more than 50 separate cases across multiple federal district courts. Several cases have been consolidated in the U.S. District Court for the District of Columbia.
| Detail | Info |
|---|---|
| Number of Lawsuits | 50+ federal cases as of early 2026 |
| Total Funding at Stake | Over $30 billion in approved grants |
| Primary Courts | D.C. District Court, Massachusetts District Court |
| Key Law Cited | Administrative Procedure Act (APA) |
| First Major Filing | Early 2025 |
The core legal question is simple: can the executive branch cancel congressionally appropriated research funds without following the legal process?
NIH Grant Cancellation Lawsuit 2026
The NIH grant cancellation lawsuit landscape in 2026 has expanded far beyond the initial cases. New lawsuits are being filed almost weekly as more institutions discover the full scope of their losses.
In the first quarter of 2026, several significant developments reshaped the litigation. The Association of American Medical Colleges (AAMC) filed a coordinated action on behalf of more than 100 member institutions. This marked the shift from individual university lawsuits to organized coalition efforts.
Federal judges have issued conflicting rulings. Some courts have granted preliminary injunctions blocking specific terminations. Others have sided with the government, ruling that NIH has discretionary authority over grant management.
The split in rulings means the issue is almost certainly headed to appellate courts. Legal experts expect at least one case to reach a federal circuit court of appeals by mid-2026.
- Over 100 institutions are now part of coordinated legal efforts
- Conflicting federal court rulings create legal uncertainty
- Appellate court action is expected by mid-to-late 2026
- New termination notices continue to arrive at universities
This legal patchwork makes 2026 the most active year for NIH grant litigation in history.
NIH Grants Terminated: Why
NIH grants were terminated for several stated reasons, though critics argue the real motivations are political. The government has pointed to three main justifications: cost savings, policy realignment, and compliance concerns.
Reason 1: DEIA-Related Policies. The administration issued executive orders in early 2025 directing federal agencies to end funding tied to diversity, equity, inclusion, and accessibility (DEIA) initiatives. NIH used broad keyword searches to flag grants with DEIA-related language.
Reason 2: Indirect Cost Rate Caps. The government proposed capping indirect cost reimbursements at 15%, far below the negotiated rates most universities hold (typically 50% to 70%). This made many grants financially unworkable.
Reason 3: DOGE-Driven Budget Cuts. The Department of Government Efficiency recommended sweeping cuts across HHS, and NIH became a primary target.
Researchers have pushed back hard. Many terminated grants had nothing to do with DEIA. The keyword-search approach flagged studies about cell diversity, genetic diversity in disease populations, and community health equity.
| Stated Reason | What It Actually Affected |
|---|---|
| DEIA policy compliance | Grants mentioning diversity in any context |
| Indirect cost rate cap (15%) | Nearly every research university in the country |
| DOGE budget recommendations | Broad cuts across all NIH institutes |
The result was a dragnet that swept up basic cancer research, Alzheimer's studies, and infectious disease work alongside the targeted DEIA programs.
Key Takeaway: The NIH grants termination lawsuit involves 50+ federal cases challenging over $30 billion in canceled research funding, driven by DEIA policy changes, cost-rate caps, and sweeping budget cuts.
Who Is Affected by NIH Grant Cuts
The people affected by NIH grant cuts include a much wider group than most headlines suggest. It's not just university administrators. The cuts ripple through entire research ecosystems.
Principal investigators (the lead scientists on grants) are the most directly impacted. When a grant is terminated, their lab loses its funding source. Many have had to lay off staff.
Postdoctoral researchers are among the most vulnerable. These early-career scientists typically depend on a single grant for their salary. No grant means no paycheck, and in many cases, no visa sponsorship for international postdocs.
Graduate students funded through NIH training grants (T32s) and research assistantships face the loss of tuition support and stipends. Some have been forced to leave their programs entirely.
Lab technicians and research staff are often the first to be let go. These are skilled workers, not easily replaced once funding returns.
- Principal investigators losing lab funding
- Postdoctoral scholars losing salaries and visa status
- Graduate students losing tuition and stipend support
- Lab technicians and research coordinators losing jobs
- Clinical trial participants losing access to experimental treatments
- Patient advocacy groups losing research partnerships
Entire communities built around research hospitals and medical schools feel the effect. When a major university cuts its research workforce, local economies take a hit too.
NIH DEIA Grant Terminations
NIH DEIA grant terminations are the most politically charged piece of this legal fight. The government targeted grants it classified as supporting diversity, equity, inclusion, and accessibility programs.
The process was blunt. NIH staff used automated keyword searches across grant abstracts and project descriptions. Any grant containing words like "diversity," "equity," "inclusion," "underrepresented," or "disparities" was flagged for review and potential termination.
This approach created serious problems. A cancer study examining genetic diversity in tumor cells got flagged. Research on health disparities in rural communities was terminated. Even studies using the word "community" in certain contexts were caught.
By early 2026, an estimated 1,500 to 2,000 grants had been terminated or suspended specifically under the DEIA rationale. The total funding involved exceeds $5 billion.
| DEIA Termination Detail | Info |
|---|---|
| Grants Terminated Under DEIA Flag | 1,500 to 2,000 estimated |
| Total Funding Affected | Over $5 billion |
| Method Used | Keyword search of grant abstracts |
| Common Flagged Words | Diversity, equity, disparities, inclusion |
Lawsuits challenging these terminations argue that the keyword approach was arbitrary. Courts have shown interest in this argument, with at least two judges calling the methodology "overbroad" in preliminary hearings.
NIH Terminated Grants List
A full NIH terminated grants list has not been officially published by the government, which is itself a point of legal contention. Universities and research organizations have been piecing together their own records.
The NIH has not released a public database of every terminated grant. Researchers have had to rely on individual termination notices sent to principal investigators and institutional grants offices.
Several organizations have created unofficial trackers. The AAMC maintains an internal list for its member institutions. Individual universities have published their own counts. Science advocacy groups have compiled crowdsourced data from affected researchers.
What we know about the scope:
- R01 grants (standard research grants): Thousands terminated across all NIH institutes
- T32 training grants: Hundreds suspended, affecting graduate student funding
- P30 center grants: Major research centers lost core funding
- Diversity supplements: Nearly all terminated
- SBIR/STTR grants: Small business research grants also affected
- International research collaborations: Grants involving foreign institutions flagged
The lack of transparency has itself become a legal issue. Several lawsuits include claims that NIH failed to provide adequate notice or explanation for specific terminations, violating basic administrative law requirements.
Researchers who want to check whether their specific grant was terminated should contact their institutional grants office directly.
Key Takeaway: DEIA-flagged grants make up a huge share of terminations, with an overbroad keyword search sweeping up legitimate scientific research alongside targeted diversity programs.
NIH Grant Termination Impact on Researchers
The impact on researchers goes far beyond lost funding. It has created a workforce crisis in American science. Think of it like pulling the foundation out from under a building mid-construction.
A survey conducted by a coalition of research universities in late 2025 found that more than 12,000 research positions had been eliminated or were at immediate risk due to NIH grant terminations. That number has grown in 2026.
Early-career researchers are being hit hardest. Postdocs who spent years training for independent research careers now face a job market with dramatically fewer openings. Many are leaving science entirely or relocating to research positions in Europe, Canada, and Asia.
The brain drain is real. International researchers on H-1B or J-1 visas lose their legal status when their funding disappears. They face a choice: find new sponsorship within days or leave the country.
| Impact Category | Estimated Scale |
|---|---|
| Research positions eliminated | 12,000+ |
| Postdocs at risk of visa loss | Thousands (exact number unknown) |
| Clinical trials paused or canceled | Hundreds |
| Years of research data at risk | Incalculable |
Labs that close don't just lose people. They lose biological samples, cell lines, animal colonies, and years of preliminary data that can never be recreated. The scientific cost extends far beyond any dollar figure.
Lawsuit Against NIH Grant Termination
A lawsuit against NIH grant termination can take several forms, and understanding the differences matters. Not every legal challenge works the same way.
Institutional lawsuits are the most common. A university sues the federal government (typically naming HHS and NIH leadership as defendants) in federal district court. These cases argue that the terminations violated specific federal statutes.
Coalition lawsuits involve multiple institutions filing together or through organizations like the AAMC. These carry more weight because they show a pattern of government action across many grants and institutions.
Individual lawsuits are rarer but do exist. Some principal investigators have filed personal claims, arguing breach of contract or due process violations tied to their specific grants.
- Institutional lawsuits: Filed by individual universities
- Coalition lawsuits: Filed by groups of institutions or through associations
- Individual lawsuits: Filed by principal investigators or researchers
- Congressional challenges: Lawmakers filing amicus briefs or separate legal actions
The strongest cases share a common thread. They argue that NIH terminated grants without following its own procedures, without providing required notice, and without the legal authority to override congressional appropriations.
Each type of lawsuit has different strengths. Institutional cases have strong standing. Coalition cases show systemic problems. Individual cases bring human stories into the courtroom.
Universities Suing NIH Over Grants
Universities suing NIH now span every region of the country. The list reads like a who's who of American research institutions.
Harvard University was among the first to file, challenging the termination of hundreds of grants totaling over $1 billion in funding. Harvard's case became a flashpoint when the government threatened to withhold all federal funding from the university.
Columbia University filed suit in the Southern District of New York. The University of Pennsylvania brought its case in the Eastern District of Pennsylvania. Stanford University and the entire University of California system filed in California federal courts.
Other institutions that have filed or joined lawsuits include:
- Johns Hopkins University
- Tufts University
- Duke University
- Emory University
- Northwestern University
- University of Michigan
- University of Wisconsin
- Massachusetts Institute of Technology (MIT)
- Yale University
- University of Washington
The AAMC's coordinated action brought in over 100 additional schools. Smaller research universities and medical schools that typically stay out of political fights have joined the litigation because their survival depends on NIH funding.
Some universities receive 30% to 50% of their total research budgets from NIH. Losing that funding threatens their ability to operate research programs at all.
Key Takeaway: More than 100 universities, from Harvard to small medical schools, have filed or joined lawsuits because NIH funding represents a survival-level financial issue for American research institutions.
Administrative Procedure Act NIH Lawsuit
The Administrative Procedure Act (APA) is the most powerful legal weapon in these lawsuits. It's the law that governs how federal agencies must behave when they make decisions that affect people and organizations.
Under the APA, federal agencies cannot take actions that are "arbitrary, capricious, an abuse of discretion, or otherwise not in accordance with law." That's the legal standard found in APA Section 706.
Universities argue that NIH's grant terminations fail this test on multiple grounds:
- No notice and comment: Major policy changes typically require public notice and a comment period. NIH skipped this step entirely.
- No individual review: Grants were flagged by keyword searches rather than reviewed on their scientific merits.
- No adequate explanation: Termination notices lacked specific reasons tied to each grant.
- Violation of appropriations: Congress had already approved the funding. The executive branch cannot unilaterally cancel appropriated funds.
The APA claim is strong because it puts the burden on the government. NIH has to show that its decision-making process was reasonable. When termination letters are form letters generated by keyword searches, that's a tough argument to make.
| APA Legal Standard | How It Applies |
|---|---|
| Arbitrary and capricious | Keyword-based termination without individual review |
| Notice and comment required | No public rulemaking process followed |
| Agency must explain decisions | Generic termination letters, no grant-specific reasoning |
| Must follow own procedures | NIH's own grants policy manual requires specific steps |
Courts have been receptive to APA arguments. Several preliminary injunctions have been granted specifically on APA grounds.
NIH Grant Termination Court Ruling
NIH grant termination court rulings in 2025 and 2026 have gone in both directions, creating a complicated legal picture. No single ruling has resolved the issue.
The most significant early ruling came from the U.S. District Court for the District of Massachusetts. The judge issued a temporary restraining order blocking NIH from terminating a batch of grants at several Boston-area universities. The court found that the plaintiffs showed a "likelihood of success on the merits."
In the D.C. District Court, a different judge issued a broader preliminary injunction covering grants terminated under the DEIA keyword search. The court called the keyword methodology "insufficiently tailored" and ordered NIH to reinstate affected grants pending full litigation.
Not every ruling favored the universities. A judge in the Southern District of New York declined to issue injunctive relief, ruling that NIH retained discretionary authority over grant management and that the plaintiffs hadn't shown irreparable harm with enough specificity.
Key rulings so far:
- Massachusetts TRO (2025): Blocked specific terminations, favored plaintiffs
- D.C. Preliminary Injunction (2025-2026): Blocked DEIA-related terminations broadly
- New York Denial (2025): Denied injunctive relief, favored government
- California TRO (2026): Blocked UC system terminations temporarily
- Fourth Circuit (pending): First appellate case expected mid-2026
The split in rulings makes appellate review almost inevitable. The outcome at the circuit court level will shape everything that follows.
NIH Grant Reinstatement Court Order
An NIH grant reinstatement court order means a judge has directed the government to restore previously terminated grants. Several such orders have been issued, but compliance has been uneven.
The D.C. District Court's preliminary injunction technically required NIH to reinstate grants terminated under the DEIA keyword search. In practice, NIH's compliance has been slow and incomplete.
Universities report that even when courts order reinstatement, the actual process of restoring funding takes weeks or months. NIH has to reissue Notice of Award documents, release frozen funds, and update its electronic systems.
Some institutions have received partial reinstatement. The grant is technically active again, but only for a limited period. Others report that NIH reinstated the grant on paper but placed new conditions or reduced the funding amount.
| Reinstatement Issue | Status |
|---|---|
| Court orders issued | Multiple, across several districts |
| NIH compliance speed | Slow, often weeks to months |
| Full reinstatement vs. partial | Many grants only partially restored |
| New conditions added | Some reinstated grants carry new restrictions |
| Funding levels restored | Often reduced from original amounts |
The gap between court orders and actual reinstatement is a growing source of frustration. Some plaintiffs have returned to court to file contempt motions, arguing that NIH is not complying in good faith.
This pattern, where the government technically obeys a court order while practically undermining it, is something courts are watching closely.
Key Takeaway: Courts have split on NIH grant termination cases, with several issuing reinstatement orders, but NIH compliance has been slow and incomplete, prompting contempt motions from frustrated universities.
Can Researchers Sue NIH for Grant Termination
Individual researchers can potentially sue NIH for grant termination, but they face different legal hurdles than institutions. The answer depends on the specific circumstances of each case.
Standing is the first question. To sue in federal court, a plaintiff must show they suffered a concrete injury caused by the defendant's action. A principal investigator whose grant was terminated has a clear injury: lost funding. But NIH grants are technically awarded to institutions, not individuals.
This creates a legal wrinkle. The university is the official grantee. The researcher is named on the grant but isn't a party to the grant agreement with NIH. Some courts have allowed individual researchers to join institutional lawsuits as co-plaintiffs.
Researchers may have stronger individual claims in specific situations:
- Contract claims: If a researcher had an employment contract tied to the grant
- Due process claims: If the termination affected a property or liberty interest
- Whistleblower retaliation: If the termination appears retaliatory
- Visa-related claims: If the loss of funding leads to loss of immigration status
Several individual researchers have filed suit. The outcomes are still pending. Legal experts suggest that individual claims work best when joined to institutional lawsuits rather than filed independently.
The practical reality is that most researchers rely on their university to fight the legal battle. That's not always comfortable, especially when the researcher's interests and the university's interests don't perfectly align.
How to Join NIH Grant Lawsuit
Joining an NIH grant lawsuit depends on who you are and what kind of legal action makes sense. There's no single sign-up form, but there are clear paths forward.
For universities and research institutions: Contact the AAMC or your institution's general counsel. The AAMC coordinated action provides a framework for institutions to join the coalition lawsuit. Individual institutions can also file their own cases.
For principal investigators: Talk to your institution's grants office and legal team first. Your university may already be pursuing litigation that covers your grants. If not, you can explore joining as a co-plaintiff.
For postdocs, graduate students, and staff: Your options are more limited but not zero. If you lost your position due to a grant termination, document everything. Employment claims may be available depending on your state.
Steps to take right now:
- Document your losses. Save termination notices, emails, funding records, and any communication from NIH or your institution.
- Contact your institution's grants office. Ask whether your grant is included in any pending litigation.
- Reach out to legal organizations. Groups like the American Civil Liberties Union (ACLU) and certain legal aid organizations are tracking these cases.
- Connect with researcher advocacy groups. Organizations representing scientists are coordinating information and resources.
- Consult with an attorney. If you have individual claims (contract violations, visa issues, retaliation), a lawyer specializing in federal administrative law can evaluate your situation.
| Who You Are | Best Path Forward |
|---|---|
| University/Institution | Join AAMC coordinated action or file independently |
| Principal Investigator | Work with institution's legal team; consider co-plaintiff status |
| Postdoc/Graduate Student | Document losses; explore employment claims |
| Lab Staff/Technician | Document job loss; check state employment protections |
Don't wait to start documenting. Even if you're not sure about legal action now, records created in real time are far more valuable than memories reconstructed later.
NIH Research Funding Lawsuit Update
The latest NIH research funding lawsuit update as of 2026 shows the legal fight intensifying on multiple fronts. New cases are being filed while existing cases move toward critical hearings.
January to March 2026: The AAMC coalition lawsuit was formally filed in the D.C. District Court, representing over 100 member institutions. This consolidated action is now the largest single case in the litigation.
Appellate activity: The government has appealed several preliminary injunctions to circuit courts. The D.C. Circuit and the First Circuit both have pending cases. Oral arguments are expected by mid-2026.
Congressional involvement: Members of Congress from both parties have filed amicus briefs in various cases. A bipartisan group of senators submitted a brief arguing that the terminations violate the Impoundment Control Act.
New legal theories: Some recent lawsuits have added claims under the Antideficiency Act, arguing that NIH cannot refuse to spend funds that Congress specifically directed it to distribute.
Recent developments at a glance:
- AAMC coalition lawsuit filed (Q1 2026)
- First appellate oral arguments scheduled (mid-2026)
- Bipartisan congressional amicus briefs filed
- New Antideficiency Act claims added to several cases
- NIH internal review process announced but not yet implemented
- Government requests to dismiss multiple cases denied
The pace of litigation is accelerating. Courts are treating these cases with urgency because of the ongoing harm to research programs. Several judges have placed cases on expedited schedules.
Key Takeaway: The litigation is escalating in 2026, with the AAMC coalition case, appellate court activity, and new legal theories all pushing toward a potential resolution at the circuit court level.
NIH Grant Termination Timeline
The NIH grant termination timeline stretches from late 2024 through 2026, with key events that built on each other. Here's the chronological picture.
| Date | Event |
|---|---|
| November 2024 | New administration elected; DOGE formed to identify spending cuts |
| January 2025 | Executive orders targeting DEIA programs across federal agencies |
| February 2025 | NIH begins keyword-based review of active grants |
| March 2025 | First batch of DEIA-related grant termination notices sent |
| April 2025 | Harvard, Columbia file first lawsuits |
| May 2025 | Indirect cost rate cap proposed at 15% |
| June 2025 | First temporary restraining orders issued by federal courts |
| Summer 2025 | Broader grant terminations beyond DEIA begin |
| Fall 2025 | Multiple preliminary injunctions issued; some denied |
| Q1 2026 | AAMC coalition lawsuit filed; 100+ institutions joined |
| Q2 2026 (expected) | First appellate oral arguments |
| Q3-Q4 2026 (expected) | Circuit court rulings; potential Supreme Court petition |
The timeline shows a pattern of escalation. What started as targeted DEIA cuts expanded into broader funding terminations. Legal challenges grew from individual university filings to massive coordinated actions.
Each phase triggered the next. The keyword searches led to over-broad terminations. The over-broad terminations triggered lawsuits. The lawsuits triggered government pushback. The pushback triggered coalition efforts.
Understanding this timeline matters because it shows where the legal fight is headed. The next major milestone is the circuit court level, and that's likely to come in the second half of 2026.
NIH Funding Cuts Legal Challenge
The NIH funding cuts legal challenge rests on a foundation of statutory and constitutional law that goes well beyond grant management. At its core, this fight is about the balance of power between Congress and the executive branch.
Congress appropriates money. That's its constitutional job. When Congress passes a budget that includes NIH research funding, the executive branch is legally obligated to distribute those funds. The president cannot simply decide not to spend money that Congress has directed.
This principle comes from the Impoundment Control Act of 1974. After President Nixon tried to withhold congressionally appropriated funds, Congress passed a law making that illegal without specific congressional approval.
The legal challenge builds on this framework:
- Impoundment: The executive branch is withholding funds Congress appropriated
- APA violations: NIH didn't follow proper administrative procedure
- Constitutional spending power: Only Congress controls the purse
- Due process: Grant recipients had a protected interest in approved funding
- Contract law: Grant awards create binding legal obligations
This isn't just about science funding. The outcome of these cases will set precedents for how any future administration can handle congressionally appropriated funds across every federal agency.
If the courts rule that the executive branch can unilaterally cancel approved grants, the precedent would extend far beyond NIH. It would affect every federal funding program.
NIH Lawsuit Settlement
An NIH lawsuit settlement has not been reached as of early 2026. However, the possibility of settlement is a topic of growing discussion among legal observers and university leaders.
Settlement in government litigation looks different from typical lawsuits. There's no pot of money to divide. A settlement would likely involve the government agreeing to specific terms about how it handles grant terminations going forward.
Possible settlement terms could include:
- Reinstatement of specific terminated grants with full funding restored
- New procedures requiring individual review before any grant can be terminated
- Withdrawal of the 15% indirect cost cap or a negotiated compromise rate
- A moratorium on further terminations while new policies are developed
- Payment of attorneys' fees to prevailing plaintiffs
Some legal experts doubt that settlement is realistic given the current political dynamics. The administration has shown no willingness to back down, and the universities feel they have strong legal positions.
| Settlement Factor | Current Status |
|---|---|
| Government willingness to negotiate | Low as of early 2026 |
| University willingness to settle | Moderate; depends on terms |
| Court pressure for resolution | Increasing |
| Political dynamics | Highly polarized |
| Most likely resolution path | Circuit court rulings, not settlement |
The more likely outcome, at least in the near term, is that circuit courts will issue binding rulings. Those rulings could then create the conditions for settlement negotiations by establishing which side has the stronger legal position.
If circuit courts side with the universities, the government may face practical pressure to settle rather than risk a Supreme Court case it might lose.
Key Takeaway: No settlement has been reached. The most likely path to resolution runs through the federal appellate courts, with circuit court rulings expected in the second half of 2026 that could reshape the entire fight.
Frequently Asked Questions
What is the NIH grants termination lawsuit about?
The NIH grants termination lawsuit challenges the federal government's mass cancellation of research grants.
Universities and researchers argue that NIH violated the Administrative Procedure Act, the Impoundment Control Act, and due process rights by terminating billions in approved funding without proper procedures.
More than 50 separate federal lawsuits are pending as of 2026.
Who qualifies to join the NIH grant lawsuit?
Universities, research institutions, and principal investigators whose NIH grants were terminated may have standing to sue.
Postdocs, graduate students, and lab staff may have related employment claims depending on their circumstances.
Contact your institution's legal team or the AAMC for guidance on joining coordinated legal efforts.
How much money is involved in the NIH grant terminations?
Over $30 billion in previously approved NIH grants have been terminated or frozen.
DEIA-related terminations alone account for more than $5 billion in affected funding.
Individual grants range from tens of thousands to tens of millions of dollars each.
Have any courts blocked the NIH grant terminations?
Yes, several federal courts have issued temporary restraining orders and preliminary injunctions blocking specific terminations.
The D.C. District Court issued a broad injunction covering DEIA-related terminations.
However, other courts have declined to block the cuts, creating a split that will likely require appellate resolution.
When will the NIH grant lawsuits be resolved?
Appellate court oral arguments are expected by mid-2026.
Circuit court rulings could come in the second half of 2026 or early 2027.
A final Supreme Court resolution, if it gets that far, could take until 2027 or 2028.
The NIH grants termination lawsuit is far from over. The fight is moving to the appellate courts, where rulings in 2026 will determine whether these cuts stand or fall.
If you're a researcher, university employee, or anyone affected by these terminations, start documenting your losses now. Contact your institution's legal team. Stay connected to organizations tracking the litigation.
This is one of those rare legal battles where the outcome affects not just the plaintiffs, but the future of scientific research in America.
